This book investigates the critical criteria and strategic methodologies required to effectively select and manage Contract Research Organizations (CROs) within the pharmaceutical and biotechnology industries. Author Shayne C. Gad, a recognized expert in toxicology and drug development, provides a systematic framework for evaluating service providers. The text addresses the financial and operational risks inherent in outsourcing research, offering a structured approach to ensure project alignment with regulatory standards and corporate objectives.

Experts in the pharmaceutical industry identify this work as a practical manual for project managers and procurement specialists. Readers frequently note the technical density of the prose, which serves as a foundational resource for those navigating the complexities of outsourced drug development.